C4 Therapeutics sets cemsidomide trial timelines through 2028
Go back to C4 Therapeutics sets cemsidomide trial timelines through 2028| Cache Capital Corp. (NASDAQ: CCCC) | Delayed: 4.40 +0.14 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.26 | 52 Week High | $0.30 | |||
| Open | $4.25 | 52 Week Low | $0.30 | |||
| Day High | $4.50 | P/E | N/A | |||
| Day Low | $4.25 | EPS | $0.00 | |||
| Volume | 1,233,714 | |||||
